Merson MH. The HIV–AIDS Pandemic at 25—The Global Response. N Engl J Med. 2006;354:2414–7.
Article
CAS
PubMed
Google Scholar
UNAIDS: The Gap Report. 2014 [http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf].
Hogg RS, Heath KV, Yip B, Craib KJ, O’Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450–4.
Article
CAS
PubMed
Google Scholar
Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–60.
Article
PubMed
Google Scholar
Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, et al. Continued improvement in survival among HIV infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007;21(6):685–92.
Article
PubMed
Google Scholar
Boyd MA. Improvements in antiretroviral therapy outcomes over calendar time. Curr Opin HIV AIDS. 2009;4(3):194–9.
Article
PubMed
Google Scholar
Public Health Agency of Canada: HIV and AIDS in Canada: Surveillance Report to December 31st, 2011. [http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2011/dec/index-eng.php].
The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.
Article
PubMed Central
Google Scholar
Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8, e81355.
Article
PubMed
PubMed Central
Google Scholar
Marin B, Thiebaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23(13):1743–53.
Article
PubMed
PubMed Central
Google Scholar
Hooshyar D, Hanson DL, Wolfe M, Selik RM, Buskin SE, McNaghten AD. Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS. 2007;21(15):2093–100.
Article
PubMed
Google Scholar
Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17(4):118–23.
PubMed
Google Scholar
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV infected adults. New Engl J Med. 2005;352:48–62.
Article
CAS
PubMed
Google Scholar
Palmer AK, Klien MB, Raboud J, Cooper C, Hosein S, Loutfy M, et al. Cohort profile: the Canadian Observational Cohort Collaboration. Int J Epidemiol. 2011;40(1):25–32.
Article
PubMed
Google Scholar
Chiang CL. The life table and its construction. In: Introduction to stochastic processes in biostatistics. New York: John Wiley and Sons; 1968. p. 189–214.
Google Scholar
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, et al. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol. 2012;41(6):1807–20.
Article
PubMed
PubMed Central
Google Scholar
Lewden C, Jougla E, Alioum A, Pavillon G, Lievre L, Morlat P, et al. Number of deaths among HIV-infected adults in France in 2000, three-source data capture-recapture estimation. Epidemiol Infect. 2006;134:1345–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–16.
Article
PubMed
Google Scholar
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grossjurth H, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.
Article
PubMed
PubMed Central
Google Scholar
Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa [Letter]. JAMA. 2008;300:506–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klein MB, Potter M, Rouleau D, Cox J, Yang H, Saeed S, for the Canadian Co-infection Cohort. Excessive short-term mortality and causes of death in HIV and HCV co-infection: the importance of losses to follow-up. 18th Annual Canadian Conference on HIV/AIDS Research, April 2009.
The Human Mortality Database: Canada. Complete data series. 2006. [http://www.mortality.org].
Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Walker AS, et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003;362(9392):1267–74.
Article
PubMed
Google Scholar
Hogg RS, Samji H, Cescon A, Modur S, Nepravnik S, Martin J, Gill J, Klein MB, Kirk G, Gange S; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Temporal Changes in Life Expectancy of HIV-positive Individuals: North America. 19th Conference on Retroviruses and Opportunistic Infections; March 8 2012. [http://www.retroconference.org/2012b/Abstracts/44961.htm].
World Health Organization. Global Health Observatory Data Repository. Life Expectancy Data by Country; 2012. [http://apps.who.int/gho/data/view.main.680?lang=en].
Statistics Canada: Life expectancy, at birth and at age 65, by sex and by province and territory, 2007/2009. [http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/health72a-eng.htm].
Belvedere L, Miller C, Hogg RS. Shifting sands: changing regional and gender-specific patterns of HIV/AIDS mortality in Canada, 1987 to 2008. Can J Public Health. 2012;103(3):202–6.
PubMed
Google Scholar
Lemly DC, Shepherd BE, Hulgan T, Rebeiro P, Stinnette S, Blackwell RB, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis. 2009;199(7):991–8.
Article
PubMed
Google Scholar
Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001;15(9):1115–23.
Article
CAS
PubMed
Google Scholar
May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ. 2011;343:d6016.
Article
PubMed
PubMed Central
Google Scholar
Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, et al. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol. 2008;168(5):532–40.
Article
PubMed
Google Scholar
Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.
Article
CAS
PubMed
Google Scholar
Laurenco L, Colley G, Nosyk B, Shopin D, Montaner JSG, Lima V. High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada. Plos One. 2014;9(12), e115277.
Article
Google Scholar
Colley G, Cescon A, Raboud J, Shurgold S, Klein MB, Cooper C, Loutfy MR, Machouf N, Tsoukas C, Montaner JSG, Hogg RS. Continuum of HIV Treatment in Canada, 2003-2012. 23rd Annual Canadian Conference on HIV/ AIDS Research (CAHR 2014); May 2014 [http://www.cahr-acrv.ca/wp-content/uploads/2012/10/CAHR-2014-Abstract-Book.pdf].
Martin LJ, Houston S, Yasui Y, Wild TC, Saunders LD. All-cause and HIV-related mortality rates among HIV-infected patients after initiating highly active antiretroviral therapy: the impact of aboriginal ethnicity and injection drug use. Can J Public Health. 2011;102(2):90–6.
PubMed
Google Scholar
Tyndall MW, Craib KJ, Currie S, Li J, O’Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. JAIDS. 2011;28:351–7.
Google Scholar
Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33(4):562–9.
Article
CAS
PubMed
Google Scholar
Cescon A, Chan K, Raboud JM, Burchell AN, Forrest JI, Klein MB, et al. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS. 2014;28(1):121–7.
Article
PubMed
Google Scholar
Klein MB, Rollet-Kurhajec KC, Moodie KC, Yaphe S, Tyndall M, Walmsley S, et al. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). AIDS. 2014;28(13):1957–65.
Article
PubMed
Google Scholar
Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral Treatment of Adult HIV Infection: 2014 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2014;312(4):410-25.
Statistics Canada: Remaining life expectancy at age 25 and probability of survival to age 75, by socio-economic status and Aboriginal ancestry. [http://www.statcan.gc.ca/pub/82-003-x/2011004/article/11560-eng.htm].
Touloumi G, Pocock SJ, Babiker AG, Darbyshire JH. Impact of missing data due to selective dropouts in cohort studies and clinical trials. Epidemiology. 2002;13(3):347–55.
Article
PubMed
Google Scholar